Safety and blood levels of mavrilimumab in Japanese volunteers;v1

• Research type

  Research Study

• Full title

  A Phase 1, Randomized, Double-blind, Placebo-controlled, Single-dose Study to Evaluate the Pharmacokinetics, Immunogenicity, and Safety of Mavrilimumab in Healthy Japanese Subjects

• IRAS ID

  155584

• Contact name

  Malcolm Boyce

• Contact email

  rec@hmrlondon.com

• Eudract number

  2014-001190-14

• ISRCTN Number

  n/a

• REC name

  London - Harrow Research Ethics Committee

• REC reference

  14/LO/0659

• Date of REC Opinion

  20 Jun 2014

• REC opinion

  Further Information Favourable Opinion